- Home
- PHAR vs IFN Comparison
PHAR vs IFN Comparison
Compare PHAR & IFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- IFN
- Stock Information
- Founded
- PHAR 1988
- IFN 1993
- Country
- PHAR Netherlands
- IFN Singapore
- Employees
- PHAR N/A
- IFN N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- IFN Finance/Investors Services
- Sector
- PHAR Health Care
- IFN Finance
- Exchange
- PHAR Nasdaq
- IFN Nasdaq
- Market Cap
- PHAR 587.5M
- IFN 560.2M
- IPO Year
- PHAR N/A
- IFN N/A
- Fundamental
- Price
- PHAR $8.37
- IFN $15.75
- Analyst Decision
- PHAR Strong Buy
- IFN
- Analyst Count
- PHAR 3
- IFN 0
- Target Price
- PHAR $30.00
- IFN N/A
- AVG Volume (30 Days)
- PHAR 7.9K
- IFN 135.2K
- Earning Date
- PHAR 03-13-2025
- IFN 01-01-0001
- Dividend Yield
- PHAR N/A
- IFN 8.68%
- EPS Growth
- PHAR N/A
- IFN N/A
- EPS
- PHAR N/A
- IFN N/A
- Revenue
- PHAR $297,200,000.00
- IFN N/A
- Revenue This Year
- PHAR $8.26
- IFN N/A
- Revenue Next Year
- PHAR $9.73
- IFN N/A
- P/E Ratio
- PHAR N/A
- IFN N/A
- Revenue Growth
- PHAR 21.15
- IFN N/A
- 52 Week Low
- PHAR $6.65
- IFN $14.40
- 52 Week High
- PHAR $11.30
- IFN $21.25
- Technical
- Relative Strength Index (RSI)
- PHAR 42.39
- IFN 57.63
- Support Level
- PHAR $8.03
- IFN $14.60
- Resistance Level
- PHAR $8.85
- IFN $15.88
- Average True Range (ATR)
- PHAR 0.33
- IFN 0.20
- MACD
- PHAR -0.00
- IFN 0.09
- Stochastic Oscillator
- PHAR 39.67
- IFN 77.18
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About IFN India Fund Inc. (The)
India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing primarily in the equity securities of Indian companies. The company's portfolio is non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities and others. Geographically, all the business activity functions through the market of United States.